FIELD: biotechnology.
SUBSTANCE: group of inventions relates to proteins of fungal luciferin biosynthesis, which are hispidin synthase. The following is proposed: new hispidin synthases, encoding their nucleic acids, expression cassettes and host cells for producing these enzymes, the use of hispidin synthases in the biosynthesis of fungal luciferin and in the method of biosynthesis of fungal pre-luciferin in both in vitro and in vivo systems.
FIELD: inventions provide an effective method of the synthesis of hispidin and luciferin from fungi and can be used to obtain autonomous bioluminescent systems with visible luminescence.
19 cl, 9 dwg, 6 tbl, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LUCIFERIN BIOSYNTHESIS ENZYMES AND USE THEREOF | 2018 |
|
RU2730038C2 |
| CAFFEYLPYRUVATE HYDROLASES AND THEIR USE | 2020 |
|
RU2812474C2 |
| TYPE III POLYKETIDE SYNTHASES AND USE THEREOF | 2020 |
|
RU2822532C2 |
| METHODS AND PRODUCTS FOR PRODUCING AND DELIVERING NUCLEIC ACIDS | 2015 |
|
RU2714404C2 |
| IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN | 2012 |
|
RU2763298C2 |
| MULTIMERIZING POLYPEPTIDES DERIVED FROM DOMAIN WITH ROLL-TYPE PENTONE BASE OF ADENOVIRUS | 2019 |
|
RU2820522C2 |
| HPV-SPECIFIC BINDING MOLECULES | 2018 |
|
RU2804664C2 |
| MUTATIONS IN OAS1 GENES | 2006 |
|
RU2465328C2 |
| COMPOSITIONS CONTAINING CURONES AND WAYS OF APPLICATION THEREOF | 2018 |
|
RU2822800C2 |
| CD123-SPECIFIC CHIMERIC ANTIGENIC RECEPTORS FOR CANCER IMMUNOTHERAPY | 2015 |
|
RU2727290C2 |
